<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02824809</url>
  </required_header>
  <id_info>
    <org_study_id>2413</org_study_id>
    <nct_id>NCT02824809</nct_id>
  </id_info>
  <brief_title>Association Between Testosterone Levels and COPD Severity</brief_title>
  <acronym>COPDTESTO</acronym>
  <official_title>Association Between Testosterone Levels and COPD Severity Measured by BODE Index in Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Italiano de Buenos Aires</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asociacion Argentina Medicina Respiratoria (AAMR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Italiano de Buenos Aires</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Aims of the study are estimate the association between the severity of COPD and free
      testosterone level and the prevalence of hypogonadism in adult men with stable COPD
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Free testosterone Level</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of Hypogonadism</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Hypogonadism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients with stable COPD that consult in a tertiary academic teaching hospital in
        Buenos Aires, Argentina
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults Men ≥ 45 years

          -  COPD defined according to clinical diagnosis and spirometry American thoracic society
             ( ATS) criteria

          -  Stable COPD without recent acute exacerbation (less than 2 weeks)

        Exclusion Criteria:

          -  Refusal to participate or informed consent process

          -  Those who are under treatment with testosterone replacement or anti-androgens

          -  Comorbidities: Cirrhosis, Alcoholism, cryptorchidism, panhypopituitarism, Pituitary
             adenoma.

          -  Orchiectomy

          -  Systemic glucocorticoids (equivalent dose ≥ 4 mg of prednisone in the last 3 weeks).

          -  Relative and absolute contraindications for spirometry.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horacio M Castro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HIBA, Buenos Aires Argentina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Horacio M Castro, MD</last_name>
    <phone>1567622134</phone>
    <phone_ext>054011</phone_ext>
    <email>matias.castro@hospitalitaliano.org.ar</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joaquin Maritano Furcada, MD</last_name>
    <email>joaquin.maritano@hospitalitaliano.org.ar</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <state>Buenos Aires</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horacio M Castro, MD</last_name>
      <phone>54-11-67622134</phone>
      <email>matias.castro@hospitalitaliano.org.ar</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2016</study_first_submitted>
  <study_first_submitted_qc>July 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>July 2, 2016</last_update_submitted>
  <last_update_submitted_qc>July 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Italiano de Buenos Aires</investigator_affiliation>
    <investigator_full_name>Horacio Matias Castro</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>hypogonadism</keyword>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>Severity of Illness Index</keyword>
  <keyword>Testosterone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypogonadism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

